276 related articles for article (PubMed ID: 25453261)
1. Modeling human carcinomas: physiologically relevant 3D models to improve anti-cancer drug development.
Unger C; Kramer N; Walzl A; Scherzer M; Hengstschläger M; Dolznig H
Adv Drug Deliv Rev; 2014 Dec; 79-80():50-67. PubMed ID: 25453261
[TBL] [Abstract][Full Text] [Related]
2. Lessons from patient-derived xenografts for better in vitro modeling of human cancer.
Choi SY; Lin D; Gout PW; Collins CC; Xu Y; Wang Y
Adv Drug Deliv Rev; 2014 Dec; 79-80():222-37. PubMed ID: 25305336
[TBL] [Abstract][Full Text] [Related]
3. The multicellular tumor spheroid model for high-throughput cancer drug discovery.
LaBarbera DV; Reid BG; Yoo BH
Expert Opin Drug Discov; 2012 Sep; 7(9):819-30. PubMed ID: 22788761
[TBL] [Abstract][Full Text] [Related]
4. Pathophysiologically relevant in vitro tumor models for drug screening.
Das V; Bruzzese F; Konečný P; Iannelli F; Budillon A; Hajdúch M
Drug Discov Today; 2015 Jul; 20(7):848-55. PubMed ID: 25908576
[TBL] [Abstract][Full Text] [Related]
5. Preclinical models for pediatric solid tumor drug discovery: current trends, challenges and the scopes for improvement.
Kumar S; Mokhtari RB; Yeger H; Baruchel S
Expert Opin Drug Discov; 2012 Nov; 7(11):1093-106. PubMed ID: 22998522
[TBL] [Abstract][Full Text] [Related]
6. Cancer drug discovery: recent innovative approaches to tumor modeling.
Lovitt CJ; Shelper TB; Avery VM
Expert Opin Drug Discov; 2016 Sep; 11(9):885-94. PubMed ID: 27454169
[TBL] [Abstract][Full Text] [Related]
7. Probing the relevance of 3D cancer models in nanomedicine research.
Leong DT; Ng KW
Adv Drug Deliv Rev; 2014 Dec; 79-80():95-106. PubMed ID: 24996135
[TBL] [Abstract][Full Text] [Related]
8. Evaluating drug efficacy and toxicology in three dimensions: using synthetic extracellular matrices in drug discovery.
Prestwich GD
Acc Chem Res; 2008 Jan; 41(1):139-48. PubMed ID: 17655274
[TBL] [Abstract][Full Text] [Related]
9. Development of In Vitro Co-Culture Model in Anti-Cancer Drug Development Cascade.
Xu R; Richards FM
Comb Chem High Throughput Screen; 2017; 20(5):451-457. PubMed ID: 28155598
[TBL] [Abstract][Full Text] [Related]
10. 3D cell culture systems modeling tumor growth determinants in cancer target discovery.
Thoma CR; Zimmermann M; Agarkova I; Kelm JM; Krek W
Adv Drug Deliv Rev; 2014 Apr; 69-70():29-41. PubMed ID: 24636868
[TBL] [Abstract][Full Text] [Related]
11. New insights into drug development for pediatric solid tumors: what preclinical data justify clinical trials in pediatric cancer?
Houghton PJ
Expert Rev Anticancer Ther; 2013 Oct; 13(10):1135-8. PubMed ID: 24093514
[No Abstract] [Full Text] [Related]
12. Physiologically based pharmacokinetic and pharmacodynamic modeling in cancer drug development: status, potential and gaps.
Block M
Expert Opin Drug Metab Toxicol; 2015 May; 11(5):743-56. PubMed ID: 25940026
[TBL] [Abstract][Full Text] [Related]
13. The use of 3-D cultures for high-throughput screening: the multicellular spheroid model.
Kunz-Schughart LA; Freyer JP; Hofstaedter F; Ebner R
J Biomol Screen; 2004 Jun; 9(4):273-85. PubMed ID: 15191644
[TBL] [Abstract][Full Text] [Related]
14. Chemoresistance of Cancer Cells: Requirements of Tumor Microenvironment-mimicking
Jo Y; Choi N; Kim K; Koo HJ; Choi J; Kim HN
Theranostics; 2018; 8(19):5259-5275. PubMed ID: 30555545
[TBL] [Abstract][Full Text] [Related]
15. Engineered microenvironments provide new insights into ovarian and prostate cancer progression and drug responses.
Loessner D; Holzapfel BM; Clements JA
Adv Drug Deliv Rev; 2014 Dec; 79-80():193-213. PubMed ID: 24969478
[TBL] [Abstract][Full Text] [Related]
16. Cancer-on-a-chip for Drug Screening.
Lee IC
Curr Pharm Des; 2018; 24(45):5407-5418. PubMed ID: 30727877
[TBL] [Abstract][Full Text] [Related]
17. A Novel 3D In Vitro Platform for Pre-Clinical Investigations in Drug Testing, Gene Therapy, and Immuno-oncology.
Candini O; Grisendi G; Foppiani EM; Brogli M; Aramini B; Masciale V; Spano C; Petrachi T; Veronesi E; Conte P; Mari G; Dominici M
Sci Rep; 2019 May; 9(1):7154. PubMed ID: 31073193
[TBL] [Abstract][Full Text] [Related]
18. Microfluidic 3D models of cancer.
Sung KE; Beebe DJ
Adv Drug Deliv Rev; 2014 Dec; 79-80():68-78. PubMed ID: 25017040
[TBL] [Abstract][Full Text] [Related]
19. A critical appraisal of the "human tumor stem-cell assay".
Selby P; Buick RN; Tannock I
N Engl J Med; 1983 Jan; 308(3):129-34. PubMed ID: 6336820
[No Abstract] [Full Text] [Related]
20. In vitro three-dimensional (3D) models in cancer research: an update.
Kimlin LC; Casagrande G; Virador VM
Mol Carcinog; 2013 Mar; 52(3):167-82. PubMed ID: 22162252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
